Leptin levels in fatty liver disease
This study looks at whether a hormone called leptin, which helps control hunger and body weight, is linked to a type of liver disease called MASLD (metabolic dysfunction-associated steatotic liver disease). It compares people with MASLD to healthy people to see if there's a difference. This could help doctors understand the condition better and find new ways to treat it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have a diagnosis of MASLD (fatty liver disease related to metabolic issues).
- You cannot drink a lot of alcohol (more than 20 grams a day if you're a woman, or 30 grams a day if you're a man).
- You cannot have other liver diseases, like hepatitis B or C, autoimmune hepatitis, or Wilson's disease.
- You cannot have an active infection or sudden inflammation, a current cancer, or be pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses routine blood tests to find people with advanced liver scarring caused by a condition called MASLD. If you are between 50 and 75, have certain metabolic risks, and get blood work from your primary care doctor at select centers, you may be eligible.
This study looks at how certain features of your metabolism affect a simple score (called the FAST score) in people with fatty liver disease (MASLD). It aims to help doctors better understand and manage the condition.
This study aims to better classify a common type of fatty liver disease (called MAFLD) using liver biopsy samples. It may help researchers understand different subtypes of the disease and could lead to more personalized care.
This study tests whether a program of physical activity can reduce fat in the muscles and liver of people with MASLD, a type of fatty liver disease linked to metabolism. It looks at how exercise might help improve liver health.
This study aims to build a tool to predict how MASLD-related cirrhosis (fatty liver disease leading to liver scarring) will progress. It may help doctors and patients better understand the outlook and plan care.
This study looks at how common obesity is in people with fatty liver disease (a condition where fat builds up in the liver). It aims to understand the relationship between these two conditions better, which might lead to improved care and prevention.
Hear when a new Metabolic Dysfunction-Associated Steatotic Liver Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.